Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): a randomised, double-blind, placebo-controlled phase II trial

Penella Woll, Piers Gaunt, Sarah Danson*, Nicola Steele, Samreen Ahmed, Clive Mulatero, Riyaz Shah, Jaishree Bhosle, Elizabeth Hodgkinson, Ben Watkins, Lucinda Billingham

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

79 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): a randomised, double-blind, placebo-controlled phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences